-
Clinically Interpretable Survival Risk Stratification in Head and Neck Cancer Using Bayesian Networks and Markov Blankets
Authors:
Keyur D. Shah,
Ibrahim Chamseddine,
Xiaohan Yuan,
Sibo Tian,
Richard Qiu,
Jun Zhou,
Anees Dhabaan,
Hania Al-Hallaq,
David S. Yu,
Harald Paganetti,
Xiaofeng Yang
Abstract:
Purpose: To identify a clinically interpretable subset of survival-relevant features in HN cancer using Bayesian Network (BN) and evaluate its prognostic and causal utility. Methods and Materials: We used the RADCURE dataset, consisting of 3,346 patients with H&N cancer treated with definitive (chemo)radiotherapy. A probabilistic BN was constructed to model dependencies among clinical, anatomical,…
▽ More
Purpose: To identify a clinically interpretable subset of survival-relevant features in HN cancer using Bayesian Network (BN) and evaluate its prognostic and causal utility. Methods and Materials: We used the RADCURE dataset, consisting of 3,346 patients with H&N cancer treated with definitive (chemo)radiotherapy. A probabilistic BN was constructed to model dependencies among clinical, anatomical, and treatment variables. The Markov Blanket (MB) of two-year survival (SVy2) was extracted and used to train a logistic regression model. After excluding incomplete cases, a temporal split yielded a train/test (2,174/820) dataset using 2007 as the cutoff year. Model performance was assessed using area under the ROC curve (AUC), C-index, and Kaplan-Meier (KM) survival stratification. Model fit was further evaluated using a log-likelihood ratio (LLR) test. Causal inference was performed using do-calculus interventions on MB variables. Results: The MB of SVy2 included 6 clinically relevant features: ECOG performance status, T-stage, HPV status, disease site, the primary gross tumor volume (GTVp), and treatment modality. The model achieved an AUC of 0.65 and C-index of 0.78 on the test dataset, significantly stratifying patients into high- and low-risk groups (log-rank p < 0.01). Model fit was further supported by a log-likelihood ratio of 70.32 (p < 0.01). Subgroup analyses revealed strong performance in HPV-negative (AUC = 0.69, C-index = 0.76), T4 (AUC = 0.69, C-index = 0.80), and large-GTV (AUC = 0.67, C-index = 0.75) cohorts, each showing significant KM separation. Causal analysis further supported the positive survival impact of ECOG 0, HPV-positive status, and chemoradiation. Conclusions: A compact, MB-derived BN model can robustly stratify survival risk in HN cancer. The model enables explainable prognostication and supports individualized decision-making across key clinical subgroups.
△ Less
Submitted 15 April, 2025;
originally announced April 2025.
-
Stereotactic Arrhythmia Radioablation for Refractory Ventricular Tachycardia: A Narrative Review and Exploratory Pooled Analysis of Clinical Outcomes and Toxicity
Authors:
Keyur D. Shah,
Chih-Wei Chang,
Sibo Tian,
Pretesh Patel,
Richard Qiu,
Justin Roper,
Jun Zhou,
Zhen Tian,
Xiaofeng Yang
Abstract:
Purpose: Stereotactic arrhythmia radioablation (STAR) is a non-invasive salvage therapy for refractory ventricular tachycardia (VT), especially in patients ineligible for catheter ablation. This narrative review and pooled analysis evaluates the safety, efficacy, and technical characteristics of STAR, integrating preclinical studies, case reports, case series, and clinical trials. Methods and Mate…
▽ More
Purpose: Stereotactic arrhythmia radioablation (STAR) is a non-invasive salvage therapy for refractory ventricular tachycardia (VT), especially in patients ineligible for catheter ablation. This narrative review and pooled analysis evaluates the safety, efficacy, and technical characteristics of STAR, integrating preclinical studies, case reports, case series, and clinical trials. Methods and Materials: A comprehensive review identified 86 studies published between 2015 and 2025, including 12 preclinical studies, 49 case reports, 18 case series, and 7 clinical trials. Study-level data were extracted for pooled analysis of 6- and 12-month mortality, VT burden reduction, and grade 3+ acute toxicities. Subgroup analyses were performed by delivery modality, age, left ventricular ejection fraction (LVEF), and cardiomyopathy type. Results: Pooled mortality was 16% (95% CI: 11-20%) at 6 months and 33% (95% CI: 27-38%) at 12 months. VT burden reduction at 6 months averaged 75% (95% CI: 73-77%) but showed substantial heterogeneity (I^2 = 98.8%). Grade 3+ acute toxicities occurred in 7% (95% CI: 4-10%), with heart failure being most common. Subgroup analyses suggested better outcomes in younger patients, those with NICM, and those with higher LVEF. Conclusions: STAR is a promising salvage therapy with favorable acute safety and efficacy. Outcome heterogeneity and inconsistent reporting highlight the need for standardized definitions, dosimetric protocols, and longer-term follow-up. Prospective trials and real-world registries are critical for refining STAR's role in VT management.
△ Less
Submitted 14 May, 2025; v1 submitted 30 January, 2025;
originally announced January 2025.
-
A Comparative Dosimetric Study of Proton and Photon Therapy in Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia
Authors:
Keyur D. Shah,
Chih-Wei Chang,
Pretesh Patel,
Sibo Tian,
Yuan Shao,
Kristin A Higgins,
Yinan Wang,
Justin Roper,
Jun Zhou,
Zhen Tian,
Xiaofeng Yang
Abstract:
Purpose: VT is a life-threatening arrhythmia commonly treated with catheter ablation; however, some cases remain refractory to conventional treatment. STAR has emerged as a non-invasive option for such patients. While photon-based STAR has shown efficacy, proton therapy offers potential advantages due to its superior dose conformity and sparing of critical OARs, including the heart itself. This st…
▽ More
Purpose: VT is a life-threatening arrhythmia commonly treated with catheter ablation; however, some cases remain refractory to conventional treatment. STAR has emerged as a non-invasive option for such patients. While photon-based STAR has shown efficacy, proton therapy offers potential advantages due to its superior dose conformity and sparing of critical OARs, including the heart itself. This study aims to investigate and compare the dosimetry between proton and photon therapy for VT, focusing on target coverage and OAR sparing. Methods: We performed a retrospective study on a cohort of 34 VT patients who received photon STAR. Proton STAR plans were generated using robust optimization in RayStation to deliver the same prescription dose of 25 Gy in a single fraction while minimizing dose to OARs. Dosimetric metrics, including D99, D95, Dmean, and D0.03cc, were extracted for critical OARs and VAS. Shapiro-Wilk tests were used to assess normality, followed by paired t-tests or Wilcoxon signed-rank tests for statistical comparisons between modalities, with Bonferroni correction applied for multiple comparisons. Results: Proton and photon plans achieved comparable target coverage, with VAS D95 of 24.1 +/- 1.2 Gy vs. 24.7 +/- 1.0 Gy (p=0.294). Proton therapy significantly reduced OAR doses, including heart Dmean (3.6 +/- 1.5 Gy vs. 5.5 +/- 2.0 Gy, p<0.001), lungs Dmean (1.6 +/- 1.5 Gy vs. 2.1 +/- 1.4 Gy, p<0.001), and esophagus Dmean (0.3 +/- 0.6 Gy vs. 1.6 +/- 1.3 Gy, p<0.001), while maintaining optimal target coverage. Conclusion: Proton therapy for STAR demonstrates significant dosimetric advantages in sparing the heart and other critical OARs compared to photon therapy for VT, while maintaining equivalent target coverage. These findings highlight the potential of proton therapy to reduce treatment-related toxicity and improve outcomes for VT patients.
△ Less
Submitted 3 February, 2025; v1 submitted 30 January, 2025;
originally announced January 2025.
-
Improving Deformable Image Registration Accuracy through a Hybrid Similarity Metric and CycleGAN Based Auto-Segmentation
Authors:
Keyur D. Shah,
James A. Shackleford,
Nagarajan Kandasamy,
Gregory C. Sharp
Abstract:
Purpose: Deformable image registration (DIR) is critical in adaptive radiation therapy (ART) to account for anatomical changes. Conventional intensity-based DIR methods often fail when image intensities differ. This study evaluates a hybrid similarity metric combining intensity and structural information, leveraging CycleGAN-based intensity correction and auto-segmentation across three DIR workflo…
▽ More
Purpose: Deformable image registration (DIR) is critical in adaptive radiation therapy (ART) to account for anatomical changes. Conventional intensity-based DIR methods often fail when image intensities differ. This study evaluates a hybrid similarity metric combining intensity and structural information, leveraging CycleGAN-based intensity correction and auto-segmentation across three DIR workflows. Methods: A hybrid similarity metric combining a point-to-distance (PD) score and intensity similarity was implemented. Synthetic CT (sCT) images were generated using a 2D CycleGAN model trained on unpaired CT and CBCT images to enhance soft-tissue contrast. DIR workflows compared included: (1) traditional intensity-based (No PD), (2) auto-segmented contours on sCT (CycleGAN PD), and (3) expert manual contours (Expert PD). A 3D U-Net model trained on 56 images and validated on 14 cases segmented the prostate, bladder, and rectum. DIR accuracy was assessed using Dice Similarity Coefficient (DSC), 95% Hausdorff Distance (HD), and fiducial separation. Results: The hybrid metric improved DIR accuracy. For the prostate, DSC increased from 0.61+/-0.18 (No PD) to 0.82+/-0.13 (CycleGAN PD) and 0.89+/-0.05 (Expert PD), with reductions in 95% HD from 11.75 mm to 4.86 mm and 3.27 mm, respectively. Fiducial separation decreased from 8.95 mm to 4.07 mm (CycleGAN PD) and 4.11 mm (Expert PD) (p < 0.05). Improvements were also observed for the bladder and rectum. Conclusion: This study demonstrates that a hybrid similarity metric using CycleGAN-based auto-segmentation improves DIR accuracy, particularly for low-contrast CBCT images. These findings highlight the potential for integrating AI-based image correction and segmentation into ART workflows to enhance precision and streamline clinical processes.
△ Less
Submitted 25 November, 2024;
originally announced November 2024.
-
Photon-Counting CT in Cancer Radiotherapy: Technological Advances and Clinical Benefits
Authors:
Keyur D. Shah,
Jun Zhou,
Justin Roper,
Anees Dhabaan,
Hania Al-Hallaq,
Amir Pourmorteza,
Xiaofeng Yang
Abstract:
Photon-counting computed tomography (PCCT) marks a significant advancement over conventional energy-integrating detector (EID) CT systems. This review highlights PCCT's superior spatial and contrast resolution, reduced radiation dose, and multi-energy imaging capabilities, which address key challenges in radiotherapy, such as accurate tumor delineation, precise dose calculation, and treatment resp…
▽ More
Photon-counting computed tomography (PCCT) marks a significant advancement over conventional energy-integrating detector (EID) CT systems. This review highlights PCCT's superior spatial and contrast resolution, reduced radiation dose, and multi-energy imaging capabilities, which address key challenges in radiotherapy, such as accurate tumor delineation, precise dose calculation, and treatment response monitoring. PCCT's improved anatomical clarity enhances tumor targeting while minimizing damage to surrounding healthy tissues. Additionally, metal artifact reduction (MAR) and quantitative imaging capabilities optimize workflows, enabling adaptive radiotherapy and radiomics-driven personalized treatment. Emerging clinical applications in brachytherapy and radiopharmaceutical therapy (RPT) show promising outcomes, although challenges like high costs and limited software integration remain. With advancements in artificial intelligence (AI) and dedicated radiotherapy packages, PCCT is poised to transform precision, safety, and efficacy in cancer radiotherapy, marking it as a pivotal technology for future clinical practice.
△ Less
Submitted 4 December, 2024; v1 submitted 26 October, 2024;
originally announced October 2024.
-
A Generalized Framework for Analytic Regularization of Uniform Cubic B-spline Displacement Fields
Authors:
Keyur D. Shah,
James A. Shackleford,
Nagarajan Kandasamy,
Gregory C. Sharp
Abstract:
Image registration is an inherently ill-posed problem that lacks the constraints needed for a unique mapping between voxels of the two images being registered. As such, one must regularize the registration to achieve physically meaningful transforms. The regularization penalty is usually a function of derivatives of the displacement-vector field, and can be calculated either analytically or numeri…
▽ More
Image registration is an inherently ill-posed problem that lacks the constraints needed for a unique mapping between voxels of the two images being registered. As such, one must regularize the registration to achieve physically meaningful transforms. The regularization penalty is usually a function of derivatives of the displacement-vector field, and can be calculated either analytically or numerically. The numerical approach, however, is computationally expensive depending on the image size, and therefore a computationally efficient analytical framework has been developed. Using cubic B-splines as the registration transform, we develop a generalized mathematical framework that supports five distinct regularizers: diffusion, curvature, linear elastic, third-order, and total displacement. We validate our approach by comparing each with its numerical counterpart in terms of accuracy. We also provide benchmarking results showing that the analytic solutions run significantly faster -- up to two orders of magnitude -- than finite differencing based numerical implementations.
△ Less
Submitted 5 April, 2021; v1 submitted 5 October, 2020;
originally announced October 2020.
